Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
24
datasets available to search
ShareScore release 0.9.0
Dataset results
24 results for “vulnerability identification”
Thesis data: Enhancing Vulnerability Detection: A Comparative Study of Change Identification Methods Across Granularity Levels
<p>Starting dataset used within the thesis; Enhancing Vulnerability Detection: A Comparative Study of Change Identification Methods Across Granularity Levels.</p> <p>Results of manual annotation of and extract of nonPatchTaggedCommitLinks within the NVD CVE dataset.</p>
Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques
ClinicalTrials.gov study NCT04765956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Identification of the Histologically "Vulnerable" Plaque Using Non-invasive Imaging, Biomechanical Assessment and Baroreflex Evaluation in Patients With Severe Carotid Stenosis
ClinicalTrials.gov study NCT05566080. IPD Sharing: UNDECIDED. Countries: 1. Publications: 13.
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality [Microarray]
GEO Series GSE203237. Homo sapiens. 13 samples. Type: Other.
Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance
GEO Series GSE134173. Homo sapiens. 28 samples. Type: Expression profiling by high throughput sequencing.
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma [RNA-Seq]
GEO Series GSE158893. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Identification of targetable epigenetic vulnerabilities for uveal melanoma
GEO Series GSE300710. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
VISTA: Vulnerability Identification using Semantic and Textual Analysis
<h3><strong>Dataset Metadata</strong></h3> <p>Each dataset must include metadata describing:</p> <ul> <li>File format.</li> <li>Vulnerability details.</li> <li>Data sources and preprocessing steps.</li> </ul>
Identification of Biomarkers for Stress Vulnerability and Resilience
ClinicalTrials.gov study NCT05498207. IPD Sharing: YES. Countries: 1. Publications: 0.
Identification of Carotid Plague Vulnerability by Contrast Enhanced Ultrasound: Correlation With Plague Histopathology
ClinicalTrials.gov study NCT02820207. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification of Vulnerability Factors in the Course of Pemphigus Patients
ClinicalTrials.gov study NCT02237313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of drivers and therapeutic vulnerabilities in anti-androgen resistant prostate cancer cells
GEO Series GSE130534. Homo sapiens. 42 samples. Type: Expression profiling by high throughput sequencing.
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality [PooledCRISPR].
GEO Series GSE203240. Homo sapiens. 18 samples. Type: Other.
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma [ChIP-Seq]
GEO Series GSE158915. Homo sapiens. 22 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
GEO Series GSE158916. Homo sapiens. 28 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.
GEO Series GSE203242. Homo sapiens. 31 samples. Type: Other.
Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [NRG1_MyCCaP_10722-AH]
GEO Series GSE271740. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing.
Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (ASPN)
GEO Series GSE271579. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer (NRG1)
GEO Series GSE271580. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Identification of Asporin as a HER3 ligand that exposes a therapeutic vulnerability in metastatic prostate cancer [VCaP_EnzaResistant_9817-HYW]
GEO Series GSE271742. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.